Delivery Order SPE2DX22D0010-SPE2D825FFL05

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $40K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,401.28 firm-fixed-price contract is for the delivery of Concerta ER 36 mg tablets, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract covers the delivery of Concerta ER 36 mg tablets, a prescription medication used to treat attention deficit hyperactivity disorder (ADHD). The delivery order has a ceiling value of $7,108.57 and a completion date of May 3, 2023. The contract is a firm-fixed-price type...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,965.46 firm fixed-price contract is for the delivery of Concerta ER 54 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued up to $999,999,999.00, provides a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense (DoD) worldwide. The specific delivery order, worth $10,400.68, is for Concerta ER 27 mg tablets, a medication commonly prescribed for the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Concerta ER 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $10,795.92 and a performance period ending on May 5, 2025. It is a firm-fixed-price contract, meaning the price will not change regardless of the contractor's costs. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $65,672.58 contract is for the delivery of CONCERTA ER 36 MG TABLET 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price pricing type and an ultimate completion date of July 3, 2024. This delivery order is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,288.23 firm fixed-price contract is for the delivery of 100 units of Concerta ER 36 mg tablets, a prescription medication used to treat attention deficit hyperactivity disorder (ADHD). The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $41,016.67 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of CONCERTA ER 36 MG TABLET 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 10, 2023 and utilizes a firm fixed-price pricing type. This award is associated with AmerisourceBergen's larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,832.92, is for the supply of CONCERTA ER TABS 54MG, a medication typically used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price delivery order, with an ultimate completion date of January 14, 2025. This award is part of a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,139.86, is for the supply of Concerta ER 27 mg tablets, a controlled-release formulation of the stimulant medication methylphenidate used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed-price pricing structure and an ultimate completion date...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D825FFL05
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the DLA's Indefinite Delivery Contract (IDC) SPE2DX worth up to $999,999,999.00. The delivery order, valued at $40,408.99, is for the supply of Concerta ER (methylphenidate hydrochloride) 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price, non-set-aside delivery order with a period of performance through May 6, 2025. As a prime contractor under the DLA's comprehensive pharmaceutical support IDC, AmerisourceBergen Drug Corp is positioned as a critical vendor in supplying a wide range of pharmaceutical products and medical supplies to support military and government healthcare programs.

Generated 8/4/25, 9:50 AM